EMA Highlights from March PRAC Meeting

The European Medicines Agency (EMA) has released highlights from the March meeting of the Pharmacovigilance Risk Assessment Committee (PRAC). PRAC warned about a known risk of aseptic meningitis with the chikungunya vaccine Ixchiq. An update to the product information has been recommended to reflect recent evidence. The PRAC continuously monitors the safety of medicines on the EU market.

Read source